Sulfur Defect-Engineered Biodegradable Cobalt Sulfide Quantum Dot-Driven Photothermal and Chemodynamic Anticancer Therapy

Chemodynamic therapy (CDT), as a powerful tumor therapeutic approach with low side effects and selective therapeutic efficiency, has gained much attention. However, the low intracellular content of H2O2 and the cellular bottleneck of low intracellular oxidative reaction rates at tumor sites have limited the antitumor efficacy of CDT. Herein, a series of sulfur-deficient engineered biodegradable cobalt sulfide quantum dots (CoSx QDs) were constructed for improved synergistic photothermal- and hyperthermal-enhanced CDT of tumors through regulating the photothermal conversion efficiency (PCE) and Fenton-like activity. Through defect engineering, we modulated the PCE and promoted the Fenton catalytic capability of CoSx QDs. With increasing defect sites, the Fentonlike activity improved to generate more toxic center dot OH, while the photothermal effect declined slightly. In light of above unique superiorities, the best synergistic effects of CoSx QDs were obtained through comparing their PCE and catalytic activity by regulating the sulfur defect fraction degree in these QDs during the synthetic process. In addition, the ultrasmall size and biodegradation endowed QDs with the ability to be rapidly decomposed to ions that were easily excreted after therapy, thus reducing biogenic accumulation in the body with lowered systemic side effects. The in vitro/ vivo results demonstrated that the photothermal- and hyperthermal-enhanced chemodynamic effect of CoSx QDs can enable remarkable anticancer properties with favorable biocompatibility. In this study, the defect-driven mechanism for the photothermalenhanced Fenton-like reaction provides a flexible strategy to deal with different treatment environments, holding great promise in developing a multifunctional platform for cancer treatment in the future.

Automated summary

This study developed sulfur-deficient engineered cobalt sulfide quantum dots (CoSx QDs) for improved synergistic photothermal- and hyperthermal-enhanced chemodynamic therapy (CDT) of tumors. By modulating the photothermal conversion efficiency and Fenton-like activity, the CoSx QDs exhibited remarkable anticancer properties with favorable biocompatibility. The defect-driven mechanism for the photothermal-enhanced Fenton-like reaction provides a flexible strategy for cancer treatment.